Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs

Abstract Risk factors for oropharyngeal dysphagia (OD) in elderly patients are mainly central nervous system (CNS) and structural organic diseases or presbyphagia. We analysed the OD prevalence and association of OD with multimorbidity and polypharmacy using real-life data to complete this spectrum,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ursula Wolf, Sandra Eckert, Grit Walter, Andreas Wienke, Sylva Bartel, Stefan K. Plontke, Christina Naumann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c53442fab8604bf2abaef5ca92a49853
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c53442fab8604bf2abaef5ca92a49853
record_format dspace
spelling oai:doaj.org-article:c53442fab8604bf2abaef5ca92a498532021-11-14T12:19:23ZPrevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs10.1038/s41598-021-99858-w2045-2322https://doaj.org/article/c53442fab8604bf2abaef5ca92a498532021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99858-whttps://doaj.org/toc/2045-2322Abstract Risk factors for oropharyngeal dysphagia (OD) in elderly patients are mainly central nervous system (CNS) and structural organic diseases or presbyphagia. We analysed the OD prevalence and association of OD with multimorbidity and polypharmacy using real-life data to complete this spectrum, with a focus on further and iatrogenic risk. This was a cross-sectional retrospective study based on a random sample of 200 patients admitted to a geriatric hospital. Data analysis included diagnoses, the detailed list of drugs, and an intense clinical investigation of swallowing according to Stanschus to screen for OD in each patient. The mean patient age was 84 ± 6.5 years. The prevalence of OD was 29.0%, without an effect of age, but a higher rate was found in men and in nursing home residents and an elevated risk of pneumonia. OD risk was slight in diabetes mellitus and COPD, and pronounced in CNS diseases. A relevant OD association was found, even after adjusting for CNS diseases, with antipsychotics, benzodiazepines, anti-Parkinson drugs, antidepressants, and antiepileptics. Further risk of OD was found with beta-blockers, alpha-blockers, opioids, antiemetics, antivertiginosa or antihistamines, metoclopramide, domperidone, anticholinergics, loop diuretics, urologics, and ophthalmics. From real-life data in patients with and without CNS diseases, we identified drug groups associated with a risk of aggravating/inducing OD. Restrictive indications for these drugs may be a preventative contribution, requiring implementation in dysphagia guidelines and an integrative dysphagia risk scale that considers all associated and cumulative medication risks in addition to diseases.Ursula WolfSandra EckertGrit WalterAndreas WienkeSylva BartelStefan K. PlontkeChristina NaumannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ursula Wolf
Sandra Eckert
Grit Walter
Andreas Wienke
Sylva Bartel
Stefan K. Plontke
Christina Naumann
Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
description Abstract Risk factors for oropharyngeal dysphagia (OD) in elderly patients are mainly central nervous system (CNS) and structural organic diseases or presbyphagia. We analysed the OD prevalence and association of OD with multimorbidity and polypharmacy using real-life data to complete this spectrum, with a focus on further and iatrogenic risk. This was a cross-sectional retrospective study based on a random sample of 200 patients admitted to a geriatric hospital. Data analysis included diagnoses, the detailed list of drugs, and an intense clinical investigation of swallowing according to Stanschus to screen for OD in each patient. The mean patient age was 84 ± 6.5 years. The prevalence of OD was 29.0%, without an effect of age, but a higher rate was found in men and in nursing home residents and an elevated risk of pneumonia. OD risk was slight in diabetes mellitus and COPD, and pronounced in CNS diseases. A relevant OD association was found, even after adjusting for CNS diseases, with antipsychotics, benzodiazepines, anti-Parkinson drugs, antidepressants, and antiepileptics. Further risk of OD was found with beta-blockers, alpha-blockers, opioids, antiemetics, antivertiginosa or antihistamines, metoclopramide, domperidone, anticholinergics, loop diuretics, urologics, and ophthalmics. From real-life data in patients with and without CNS diseases, we identified drug groups associated with a risk of aggravating/inducing OD. Restrictive indications for these drugs may be a preventative contribution, requiring implementation in dysphagia guidelines and an integrative dysphagia risk scale that considers all associated and cumulative medication risks in addition to diseases.
format article
author Ursula Wolf
Sandra Eckert
Grit Walter
Andreas Wienke
Sylva Bartel
Stefan K. Plontke
Christina Naumann
author_facet Ursula Wolf
Sandra Eckert
Grit Walter
Andreas Wienke
Sylva Bartel
Stefan K. Plontke
Christina Naumann
author_sort Ursula Wolf
title Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
title_short Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
title_full Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
title_fullStr Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
title_full_unstemmed Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
title_sort prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c53442fab8604bf2abaef5ca92a49853
work_keys_str_mv AT ursulawolf prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
AT sandraeckert prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
AT gritwalter prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
AT andreaswienke prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
AT sylvabartel prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
AT stefankplontke prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
AT christinanaumann prevalenceoforopharyngealdysphagiaingeriatricpatientsandreallifeassociationswithdiseasesanddrugs
_version_ 1718429313429143552